PROTAC ERα Degrader-1 - HY-112098
Nur noch %1 verfügbar
Catalog #
HY-112098
Ab
537,00 €
PROTAC ERα Degrader-1 comprises an ubiquitin E3 ligase binding group, a linker and a protein binding group. PROTAC ERα Degrader-1 extracts from patent WO2017201449A1, compound P1. PROTAC ERα Degrader-1 is an estrogen receptor-alpha (ERα) degrader.
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-112098/PROTAC-ERα-Degrader-1-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Blue Ice |
| Application | Cancer-programmed cell death |
| CAS | 2417369-94-7 |
| Storage | -20°C (Powder, stored under nitrogen) |
| MWT | 1120.29 |
| Solubility | DMSO : 200 mg/mL (ultrasonic) |
| Clinical Information | No Development Reported |
| Target | Estrogen Receptor/ERR;PROTACs |
| Application: | Cancer-programmed cell death |
|---|